• Skip to main content
  • Skip to primary navigation
  • Home
  • Community Schedule
  • Hospital Medicines (HML)
  • Application Tracker

Pharmac - Te Pātaka Whaioranga. Pharmac - Te Pātaka Whaioranga. Pharmac - Te Pātaka Whaioranga.

  • Te Rārangi Rongoā Pharmaceutical Schedule

    Pharmaceutical Schedule

    All funded medicines in New Zealand.

    • Community Schedule

    • Hospital Medicines (HML)

    • Schedule Updates

    • Schedule resources

    • About the Schedule

    • Rules of the Schedule

    • Hospital Medical Devices

  • Te pūtea me ngā umanga rongoā Medicine funding and supply

    Medicine funding and supply

    Ask us to fund a medicine | Check changes to medicines | How do generics work?

    • Make an application

    • Medicine notices (includes supply issues)

      Brand changes, discontinuations and more.

    • The funding process

    • What you need to know about medicines

    • Medicine supply management

      Order condoms and nicotine replacement | About supply management

  • Ngā pūrere hauora a te hōhipere Hospital medical devices

    Hospital medical devices

    PHARMAC contracts with device suppliers to ensure our hospitals can buy medical devices at fairer prices.

    • Category Information

      Medical devices we have contracted and the ones we're working on

    • Growing our role in medical devices

    • Device Advice

      Read and subscribe to our devices newsletter

  • Treaty of Waitangi Te Tiriti o Waitangi

    Te Tiriti o Waitangi

    • Te Whaioranga

      PHARMAC's Māori Responsiveness Strategy

    • Hauora Arotahi

      The Māori health areas of focus

    • Programmes to support Māori health

      Scholarships, awards and programmes

    • How we work with Whānau Ora

  • Ngā karere me ngā rauemi News and resources

    News and resources

    • Consultations and decisions

      includes RFPs and tenders.

    • News and updates

    • Order publications

    • Seminars

    • COVID-19

    • PHARMAC's research

    • Uptake of medicines for type 2 diabetes

      Nearly 30,000 approved Special Authority applications.

  • Mō About

    About

    • Strategic Direction

      Our plan to deliver the best health outcomes for New Zealanders

    • Pacific Responsiveness Strategy

    • Te Tiriti o Waitangi

    • What we do

    • Who we are

    • How we get expert advice

      Advice we seek to make decisions

    • Working at Pharmac

      Explore current vacancies

    • Contact us

      How to get in touch

  1. Home
  2. News and resources
  3. Consultations and decisions
  4. Approval of funding of sildenafil for Raynaud's phenomenon and bosentan for children with pulmonary arterial hypertension
  • News and resources
    • Back to Consultations and decisions

Approval of funding of sildenafil for Raynaud's phenomenon and bosentan for children with pulmonary arterial hypertension

28 January 2013
Medicines Decision

Approval of funding of sildenafil for Raynaud's phenomenon and bosentan for children with pulmonary arterial hypertension(external link)

Last updated: 28 January 2013

Back to top

Pharmac - Te Pātaka Whaioranga.

  • Community Schedule
  • Hospital Medicines (HML)
  • Application Tracker
  • Contact us
  • Follow us
  • Facebook
  • LinkedIn
  • Twitter

Shielded site.

  • Copyright
  • Disclaimer
  • Privacy statement
  • Subscribe

New Zealand Government.